FDA OKs new Johnson & Johnson schizophrenia drug

12/21/2006 | USA Today

The FDA approved Johnson & Johnson's schizophrenia drug Invega, or paliperidone, which is derived from the drug risperidone, sold under the brand name Risperdal. Invega will be sold in extended-release tablet form. The price was not released.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN